SCHEMBL8089530

SCHEMBL8089530

CCc1ccc([C](c2ccccc2)c2cccc(OC)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 1/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
PARP1 P09874 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
GPR52 Q9Y2T5 1/20 0.46
HSD11B1 P28845 1/20 0.46
MAOB P27338 2/20 0.45
POLB P06746 1/20 0.45
BLM P54132 1/20 0.45
KCNK3 O14649 1/20 0.44
KCNK9 Q9NPC2 1/20 0.44
MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1050768 0.87 CES2 (0.62) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL14361865 0.81 TP53 (0.59) NPC1RAB9ASMN1; SMN2CES2CES1
1,3-Dimethoxybenzene SCHEMBL8150411 0.79 MAOB (0.67) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL15179040 0.74 NPC1 (0.76) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL9102 0.73 CES2 (0.69) NPC1RAB9ASMN1; SMN2MAPTCES2
SCHEMBL7953 0.73 CES2 (0.69) NPC1RAB9ASMN1; SMN2MAPTCES2
SCHEMBL9253579 0.73 NPC1 (0.50) MEN1KMT2ANPC1RAB9ASMN1; SMN2
Anisole SCHEMBL27772542 0.73 CALM1 (0.56) MEN1KMT2ANPC1RAB9ASMN1; SMN2
Phenol SCHEMBL28160826 0.72 MAOB (0.57) MEN1KMT2AMAOB
SCHEMBL30542256 0.72 CES2 (0.68) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051394-A1 POTASSIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2000-11-15 EP disclosed
WO-1999037607-A1 POTASSIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 1999-07-29 WO disclosed